Rixe O - Search Results

1

Peripheral neuropathy in association with an ovarian dysgerminoma.

Ivanaj A, Pautier P, Rixe O, Duvillard P, Dubard T. Ivanaj A, et al. Among authors: rixe o. Gynecol Oncol. 2003 Apr;89(1):168-70. doi: 10.1016/s0090-8258(03)00049-0. Gynecol Oncol. 2003. PMID: 12694672

2

Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).

Pautier P, Joly F, Kerbrat P, Bougnoux P, Fumoleau P, Petit T, Rixe O, Ringeisen F, Carrasco AT, Lhommé C. Pautier P, et al. Among authors: rixe o. Gynecol Oncol. 2010 Feb;116(2):157-62. doi: 10.1016/j.ygyno.2009.10.076. Gynecol Oncol. 2010. PMID: 20109725 Clinical Trial.

3

[Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)].

Lhommé C, Ray-Coquard I, Guastalla JP, Bataillard A, Thomas L, Bonnier P, Dargent D, Dohollou N, Ganem G, Lefranc JP, Misset JL, Rixe O, Tchiknavorian X, Tournigand C, Villet R, Bachelot T, Kerbrat P, Fervers B, Basuyau JP, Cohen-Solal-Le Nir C, Morice P, Duvillard P, Voog E; Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC); Fédération Hospitalière de France (FHF); Fédération Nationale de Cancérologie des Centres Hospitaliers Régionaux Universitaires (FNCCHRU); Fédération Française de Cancérologie des Centres Hospitaliers Généraux (FFCCHG); Centres Régionaux de Lutte Contre le Cancer (CRLCC); Société Française d'Oncologie Gynécologique (SFOG). Lhommé C, et al. Among authors: rixe o. Bull Cancer. 2004 Jul-Aug;91(7-8):609-20. Bull Cancer. 2004. PMID: 15381451 Free article. French.

4

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.

Delord JP, Raymond E, Chaouche M, Ruffie P, Ducreux M, Faivre S, Boige V, Le Chevalier T, Rixe O, Baudin E, Pautier P, Rodier JM, Chouaki N, Escudier B, Kayitalire L, Armand JP. Delord JP, et al. Among authors: rixe o. Ann Oncol. 2000 Jan;11(1):73-9. doi: 10.1023/a:1008352227275. Ann Oncol. 2000. PMID: 10690391 Free article. Clinical Trial.

5

Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancer.

Boige V, Raymond E, Faivre S, Gatineau M, Meely K, Mekhaldi S, Pautier P, Ducreux M, Rixe O, Armand JP. Boige V, et al. Among authors: rixe o. J Clin Oncol. 2000 Dec 1;18(23):3986-92. doi: 10.1200/JCO.2000.18.23.3986. J Clin Oncol. 2000. PMID: 11099328 Clinical Trial.

6

Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma.

Coeffic D, Benhammouda A, Antoine EC, Rixe O, Paraiso D, Auclerc G, Renody N, Mularoni E, Soubrane C, Weil M, Mortier N, Khayat D. Coeffic D, et al. Among authors: rixe o. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-38-S2-40. Semin Oncol. 1997. PMID: 9045335 Clinical Trial.

7

Phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma: preliminary results.

Coeffic D, Benhammouda A, Antoine EC, Rixe O, Paraiso D, Auclerc G, Nizri D, Renody N, Grapin JP, Mularoni E, Rattini E, Soubrane C, Weil M, Mortier N, Khayat D. Coeffic D, et al. Among authors: rixe o. Semin Oncol. 1996 Dec;23(6 Suppl 15):5-8. Semin Oncol. 1996. PMID: 8996589 Clinical Trial.

8

Dosage adjustment and pharmacokinetic profile of irinotecan in cancer patients with hepatic dysfunction.

Raymond E, Boige V, Faivre S, Sanderink GJ, Rixe O, Vernillet L, Jacques C, Gatineau M, Ducreux M, Armand JP. Raymond E, et al. Among authors: rixe o. J Clin Oncol. 2002 Nov 1;20(21):4303-12. doi: 10.1200/JCO.2002.03.123. J Clin Oncol. 2002. PMID: 12409328 Clinical Trial.

9

Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.

Fizazi K, Cojean I, Pignon JP, Rixe O, Gatineau M, Hadef S, Arriagada R, Baldeyrou P, Comoy E, Le Chevalier T. Fizazi K, et al. Among authors: rixe o. Cancer. 1998 Mar 15;82(6):1049-55. doi: 10.1002/(sici)1097-0142(19980315)82:6<1049::aid-cncr6>3.0.co;2-9. Cancer. 1998. PMID: 9506348

10

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma.

Raymond E, Fabbro M, Boige V, Rixe O, Frenay M, Vassal G, Faivre S, Sicard E, Germa C, Rodier JM, Vernillet L, Armand JP. Raymond E, et al. Among authors: rixe o. Ann Oncol. 2003 Apr;14(4):603-14. doi: 10.1093/annonc/mdg159. Ann Oncol. 2003. PMID: 12649109 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page